-
1
Safety profiles of sevoflurane in pediatric patients: a real-world pharmacovigilance assessment based on the FAERS database
Published 2025-02-01Subjects: “…FAERS…”
Get full text
Article -
2
Expanding on Abraxane Safety: Temporal Insights and Future Directions for Adverse Event Analysis [Letter]
Published 2025-02-01Subjects: Get full text
Article -
3
Safety profiles of IDH inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
Published 2025-02-01Subjects: Get full text
Article -
4
Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
Published 2025-02-01Subjects: Get full text
Article -
5
Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
Published 2025-01-01Subjects: Get full text
Article -
6
Corrigendum: Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
Published 2025-02-01Subjects: Get full text
Article -
7
Real-world pharmacovigilance study of drug-induced autoimmune hepatitis from the FAERS database
Published 2025-02-01Subjects: “…FAERS…”
Get full text
Article -
8
Adverse events in the nervous system associated with blinatumomab: a real-world study
Published 2025-02-01Subjects: “…FDA Adverse Event Reporting System (FAERS)…”
Get full text
Article -
9
Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors
Published 2025-02-01Subjects: “…FDA adverse event reporting system (FAERS)…”
Get full text
Article